Effects of β-aminopropionitrile on equine tendon metabolism in vitro and on effects of insulin-like growth factor-I on matrix production by equine tenocytes
Authors:
- Alan J. NixonANAlan J. Nixon
- Brent D. Brower-TolandBBBrent D. Brower-Toland
- 1 October 2001
- journal article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 62 (10) , 1557-1562
Abstract
Objective—To investigate effects of β-aminopropionitrile and a combination of insulin-like growth factor (IGF)-I and β-aminopropionitrile on metabolism of equine tendon fibroblasts. Sample Population—Flexor tendon explants from 3 horses. Procedure—Explants received 1 of 4 treatments (control, IGF-I, β-aminopropionitrile, and IGF-I/β-aminopropionitrile) for 10 days, and message expression for collagen types I and III was assessed by use of in situ hybridization. Histologic findings, new protein production, and quantitative determinations of glycosaminoglycan, DNA, and de novo collagen synthesis were made. Results—Insulin-like growth factor-I stimulated an anabolic response in tendon. Collagen synthesis and glycosaminoglycan and DNA content of explants were all increased. β-Aminopropionitrile significantly suppressed collagen synthesis, which was not ameliorated by concurrent IGF-I treatment. β-Aminopropionitrile caused alterations in cell morphology characterized by large round cells with eccentric nuclei and decreased density of collagen fibers. Protein production and collagen type-III mRNA expression were reduced in these cells. Conclusion and Clinical Relevance—Treatment with β-aminopropionitrile resulted in decreased production of protein and collagen synthesis, which could be expected to suppress tendon healing. The negative effects of β-aminopropionitrile could not be abrogated by addition of IGF-I to the medium. Treatment resulted in alterations in cell morphology and matrix consistency, which could further delay tendon healing. β-Aminopropionitrile may impair tendon healing at a cellular level by decreasing collagen production or increasing rate of degradation of existing matrix. Because of reduced crosslinking during β- aminopropionitrile treatment, in combination with transiently decreased tensile strength, alterations in collagen content and structure may weaken the healing tendon. (Am J Vet Res 2001;62:1557–1562)Keywords
This publication has 15 references indexed in Scilit:
- Insulin‐like growth factor‐I is expressed by avian flexor tendon cellsJournal of Orthopaedic Research, 2000
- Differential effects of insulin‐like growth factor‐I on matrix and DNA synthesis in various regions and types of rabbit tendonsJournal of Orthopaedic Research, 1996
- Proliferative and matrix synthesis response of canine anterior cruciate ligament fibroblasts submitted to combined growth factorsJournal of Orthopaedic Research, 1996
- Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide.Journal of Cell Biology, 1991
- Long‐term explant culture of rabbit flexor tendon: Effects of recombinant human insulin‐like growth factor‐I and serum on matrix metabolismJournal of Orthopaedic Research, 1991
- Recombinant human insulin‐like growth factor‐I stimulates in vitro matrix synthesis and cell proliferation in rabbit flexor tendonJournal of Orthopaedic Research, 1991
- Somatomedin C immunoreactivity in the Achilles tendon varies in a dynamic manner with the mechanical loadActa Physiologica Scandinavica, 1988
- Epidemiological study of wastage among racehorses 1982 and 1983Veterinary Record, 1985
- In situ hybridization histochemistry with synthetic oligonucleotides: Strategies and methodsPeptides, 1985
- 1 Biological and immunological properties of insulin-like growth factors (IGF) I and IIClinics in Endocrinology and Metabolism, 1984